CanBas Co., Ltd. (TYO:4575)
665.00
-25.00 (-3.62%)
Nov 18, 2026, 10:12 AM JST
CanBas Market Cap
CanBas has a market cap or net worth of 13.15 billion as of November 17, 2026. It is the 25,863rd most valuable company in the world and the 2,205th biggest in Japan. Its market cap has decreased by 12.82% in one year.
Market Cap
13.15B
Enterprise Value
12.07B
Revenue
n/a
Global Rank
Country Rank
#2,205 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 18, 2009, CanBas's market cap has increased from 8.38B to 13.15B, an increase of 56.83%. That is a compound annual growth rate of 2.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 13.15B | -14.34% |
| Dec 30, 2025 | 15.35B | -10.38% |
| Dec 30, 2024 | 17.13B | 0.65% |
| Dec 29, 2023 | 17.01B | -5.30% |
| Dec 30, 2022 | 17.97B | 974.22% |
| Dec 30, 2021 | 1.67B | -48.57% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Japan Tissue Engineering | 26.80B |
| Innovacell | 22.80B |
| RaQualia Pharma | 19.21B |
| Stella Pharma | 13.39B |
| ReproCELL | 11.42B |
| AnGes | 10.13B |
| Immuno-Biological Laboratories | 8.46B |
| K Pharma,Inc. | 8.29B |